Status:
COMPLETED
Treatment for Mild Hip Dysplasia in Newborns
Lead Sponsor:
University of Bergen
Conditions:
Developmental Dysplasia of the Hip
Eligibility:
All Genders
1-5 years
Phase:
NA
Brief Summary
Developmental dysplasia of the hip is the most common musculoskeletal disorder in infancy, with a reported prevalence of 2% of all newborns. Although newborn screening programs based on clinical exami...
Detailed Description
140 newborns with stable (not dislocatable or dislocated) but mildly dysplastic hips, born at the Maternity Hospital, Haukeland University Hospital, from 1997 onwards. The newborns will be randomly a...
Eligibility Criteria
Inclusion
- Birth weight \> 2500 g
- Mild hip dysplasia on ultrasound day 1-2
- Written informed consent given
Exclusion
- Birth weight less than 2500 g and/or severe congenital malformation(s)
Key Trial Info
Start Date :
February 1 1998
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2003
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT00843258
Start Date
February 1 1998
End Date
April 1 2003
Last Update
February 13 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.